STAT+: Eli Lilly’s GLP-1 pill Foundayo helped alleviate sleep apnea in studies
Headline from STAT
Eli Lilly’s GLP-1 pill Foundayo helped alleviate sleep apnea in two late-stage studies, but it doesn’t appear as effective as Lilly’s injectable drug Zepbound.
STAT's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Eli Lilly’s GLP-1 pill Foundayo helped alleviate sleep apnea in two late-stage studies, but it doesn’t appear as effective as Lilly’s injectable drug Zepbound.
Eli Lilly & Co.’s weight loss pill Foundayo helped control sleep apnea in two large trials, reducing nighttime disruptions for patients and paving the way for a new use for the daily drug.